DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 51 filers reported holding DESIGN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,621 | -42.6% | 2,275 | -30.9% | 0.00% | – |
| Q1 2024 | $13,275 | -7.1% | 3,294 | -38.9% | 0.00% | – |
| Q4 2023 | $14,294 | -16.2% | 5,394 | -25.4% | 0.00% | – |
| Q3 2023 | $17,065 | -75.2% | 7,231 | -33.7% | 0.00% | – |
| Q2 2023 | $68,676 | -5.5% | 10,901 | -13.5% | 0.00% | – |
| Q1 2023 | $72,690 | -47.6% | 12,598 | -6.9% | 0.00% | – |
| Q4 2022 | $138,787 | -38.0% | 13,527 | +1.1% | 0.00% | – |
| Q3 2022 | $224,000 | +10.3% | 13,374 | -7.7% | 0.00% | – |
| Q2 2022 | $203,000 | +9.7% | 14,489 | +26.8% | 0.00% | – |
| Q1 2022 | $185,000 | -40.5% | 11,428 | -21.3% | 0.00% | – |
| Q4 2021 | $311,000 | +193.4% | 14,521 | +100.5% | 0.00% | – |
| Q3 2021 | $106,000 | -71.4% | 7,242 | -61.1% | 0.00% | – |
| Q2 2021 | $370,000 | – | 18,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |